Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells
Authors:
- Ruogu LiRLRuogu Li
- Xinkai QuXQXinkai Qu
- Weiyi FangWFWeiyi Fang
- Zhe QuanZQZhe Quan
- 1 September 2012
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 279 (1) , 96-102
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell SignalingThe Journal of Immunology, 2011
- Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and MigrationClinical Cancer Research, 2009
- Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleenAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic targetMedical Hypotheses, 2008
- Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db MiceEndocrinology, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Simvastatin Prevents Vascular Hyporeactivity During InflammationCirculation, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004
- AtherosclerosisAutoimmunity, 2004
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979